You have no items in your shopping cart.
Hamster IgG Antibody
Description
Research Area
Images & Validation
−| Tested Applications | SDS-PAGE |
|---|---|
| Application Notes |
Key Properties
−| Source | Golden Syrian Hamster |
|---|---|
| Biological Origin | Golden Syrian Hamster |
| Isotype | IgG |
| Purity | Hamster IgG whole molecule was prepared from normal serum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above. Hamster IgG whole molecule was assayed by immunoelectrophoresis resulted in a single precipitin arc against anti-GS Hamster IgG and anti-GS Hamster Serum. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store vial at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Hamster IgG whole molecule is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. |
|---|---|
| Form/Appearance | Lyophilized |
| Buffer/Preservatives | Preservative: 0.01% (w/v) Sodium Azide; Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| Concentration | 10.0 mg/mL |
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Goat Hamster IgG (heavy and light chains) Antibody [orb22055]
Hamster
Goat
Polyclonal
Unconjugated
1 mlRabbit Hamster IgG (heavy and light chains) Antibody [orb22332]
Hamster
Rabbit
Polyclonal
Unconjugated
1 mlRabbit Hamster IgG (heavy and light chains) Antibody [orb21513]
Hamster
Rabbit
Polyclonal
Unconjugated
10 mgRabbit Monkey IgG (heavy and light chains) Antibody [orb22368]
Monkey
Rabbit
Polyclonal
Unconjugated
1 ml

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Anti-CD154–facilitated alloengraftment is multilineage. Twenty mice from 2 representative experiments shown in Figure 1 were phenotyped at 120 days after BMT for donor-host origin of CD4+ and CD8 + T cells, CD19 + B cells, and MAC-1 + myeloid cells. On the x-axis are shown the host and donor proportions of each of the lineages. ▪ indicates the proportion of each lineage of host origin; ▥, the proportion of each lineage that is of donor origin. On the y-axis is shown the percentage of PBLs of each lineage. Irrelevant hIgG–treated mice had no detectable donor chimerism and thus are composed entirely of host-type cells. Note that most CD4+ T cells, CD19 + B cells, and MAC-1 + myeloid cells in anti-CD154–treated mice are of donor origin. In contrast, most of the CD8 + T cells are of host origin.

Anti-CD40L mAb alone or in combination with (A) sirolimus or (B) CsA results in long-term multilineage engraftment.

Anti-PD-1 antibody plus radiation therapy (RT) cures mice with intracranial GL261-luc tumors. (A) Experimental timeline. (B) Luciferase imaging of 4 distinct mice per treatment arm before treatment (day 7) and after treatment (day 21), divided by treatment group. All images at same scale. All mice individually matched on days 7 and 21. (C) Kaplan-Meier survival curve. P 6 mice per arm.

Combination therapy with Cy/GVAX and PD-1 or PD-L1 blockade improves clinical outcomes in a PDA mouse model. Anti-PD-1, anti-PD-L1 or IgG (5 mg/kg IP) were administered IP twice weekly until death starting on day 3. (B) Kaplan-Meier survival curves of mice that were implanted with PDA cells and were treated with different combinations of Cy, GVAX and the αPD-1 antibody. The percentages of mice that remained disease free at day 90 following tumor implantation and therapy with (C) Cy, GVAX and/or αPD-1 or (D) Cy, GVAX and αPD-L1 are shown. All the p values were yielded by comparing GVAX and/or αPD-1/αPD-L1 treatment groups with IgG treated group. (E) Kaplan-Meier survival curves of mice that were implanted with Panc02 cells via hemispleen technique and treated with different combinations of Cy, GVAX and αPD-L1 antibody. Data are represented as results obtained from experiments with 8-10 mice per group that were repeated at least twice.

SDS-PAGE Results of Golden Syrian Hamster IgG Whole Molecule. Lane 1: Golden Syrian Hamster IgG Whole Molecule, Reduced [5.0 µg]. Lane 2: Opal Pre-Stained Molecular Weight Marker. Lane 3: Golden Syrian Hamster IgG Whole Molecule, Non-Reduced [5.0 µg]. 4-20% gel, Coomassie stained.
Documents Download
Request a Document
Protocol Information
Hamster IgG Antibody (orb346158)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review